Drug intelligence / Profile preview

CYP and transporter probe substrates cocktail

Development stage
Unknown
Lead developer
ViiV Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

A cocktail of eight specific probe substrates used in clinical pharmacology to evaluate the drug-drug interaction (DDI) potential of investigational compounds. In the context of ViiV Healthcare's development of the HIV-1 maturation inhibitor BMS-955176, this cocktail was administered to healthy subjects to determine if BMS-955176 inhibits or induces key metabolic enzymes and transporters. The cocktail consists of caffeine (probes CYP1A2), metoprolol (probes CYP2D6), montelukast (probes CYP2C8), flurbiprofen (probes CYP2C9), omeprazole (probes CYP2C19), midazolam (probes CYP3A), digoxin (probes P-gp), and pravastatin (probes OATP1B1/1B3). By analyzing the plasma concentrations of these probes, researchers can predict how the investigational drug might interact with other medications commonly prescribed to HIV patients.

Other names
CYP and transporter probe substratesBMS-955176 DDI probe cocktailBMS955176 DDI probe cocktailBMS 955176 DDI probe cocktail
02

Targets

CYP2C19 (Cytochrome P450 2C19)OATP1B1 (Organic anion transporting polypeptide 1B1)CYP1A2 (Cytochrome P450 1A2)SLCO1B3 (Organic anion transporting polypeptide 1B3)ABCB1 (P-glycoprotein)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)CYP2C8 (Cytochrome P450 2C8)

Beyond the preview

Go deeper on CYP and transporter probe substrates cocktail.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CYP and transporter probe substrates cocktail.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call